BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
BRCA1
,
Fatty acid metabolic process
,
Breast Cancer
,
Liver
,
DNA fingerprint
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ici 182 780
Summary
General Info
Curated Studies
Most Correlated Studies
Uterus of COUP-TFII mutant mice treated with oil or ICI 182,780
Breast cancer MCF-7 cells treated with selective estrogen receptor modulators
Efferent ductule gene expression in rats treated with the antiestrogen fulvestrant
Cervical cancer associated fibroblasts response to estradiol or ER antagonists
MCF-7 cells coexpressing Erbeta treated with phytoestrogens
Explore Curated Studies Results
Literature
Most Relevant Literature
ICI 182,780 Attenuates Selective Upregulation of Uterine Artery Cystathionine β-Synthase Expression …
A transcriptomics model of estrogen action in the ovine fetal hypothalamus: evidence for estrogenic …
Tamoxifen and ICI 182,780 activate hypothalamic G protein-coupled estrogen receptor 1 to rapidly fac…
Effects of afala and antiestrogen ICI 182,780 in the model of hormone-dependent prostate inflammatio…
The estrogen receptor antagonist ICI 182,780 can act both as an agonist and an inverse agonist when …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Efficacy of Faslodex in Treatment of SLE Clinical, Serologic, and Molecular Studies
ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer
Second Line Breast Cancer Trial
Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic …
Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ